Compare SKYA & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKYA | ESLA |
|---|---|---|
| Founded | N/A | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.9M | 45.6M |
| IPO Year | 2022 | N/A |
| Metric | SKYA | ESLA |
|---|---|---|
| Price | $1.24 | $1.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 350.9K | 37.8K |
| Earning Date | N/A | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.91 | $0.78 |
| 52 Week High | $1.23 | $3.15 |
| Indicator | SKYA | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 67.82 | 44.46 |
| Support Level | $0.91 | $0.97 |
| Resistance Level | N/A | $1.28 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 93.07 | 52.38 |
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.